To examine the association between histological chorioamnionitis (HC) with or without fetal inflammatory response (FIR) and bronchopulmonary dysplasia (BPD) in preterm infants. STUDY DESIGN: We conducted a retrospective cohort study of infants born at o29 weeks gestation admitted to the neonatal intensive care unit from 2000 to 2006, who had placental histology. We compared the incidence of BPD among three groups: No HC group, HC without FIR group and HC with FIR group. The multivariable model based on generalized estimating equation was fitted to estimate the adjusted risk ratios (aRR) and 95% confidence intervals (CIs) for BPD and combined outcome of BPD or death. RESULT: Of 529 infants, 84 (16%) had HC without FIR, 186 (35%) had HC with FIR and 259 (49%) had no HC. Compared with the no HC group, HC with and without FIR group infants were of lower gestational age and singleton births. Multivariable modeling based on generalized estimating equation revealed that HC with FIR is associated with decreased risk of both BPD (aRR 0.88, 95% CI 0.81 to 0.95) and the combined outcome of BPD or death (aRR 0.91, 95% CI 0.86 to 0.97). HC without FIR showed a trend toward reduction in BPD (aRR 0.93, 95% CI 0.86 to 1.00). CONCLUSIONS: HC with FIR is associated with decreased risk of both BPD and the combined outcome of BPD or death in preterm infants.
INTRODUCTION
Chorioamnionitis is an important cause of preterm birth and its frequency increases with decreasing gestational age at birth. 1, 2 Chorioamnionitis is generally associated with ascending infection of the maternal lower genital tract. The maternal placental tissues are involved first, with severe or prolonged inflammation resulting in fetal involvement. In most cases, chorioamnionitis is clinically silent and is diagnosed by histological examination of the placenta, membranes and umbilical cord after delivery. Histological markers of maternal inflammatory response include neutrophilic infiltration of subchorionic space (subchorionitis), chorionic plate (chorionitis) or free placental membrane (chorioamnionitis). A fetal inflammatory response (FIR) involves acute chorionic vasculitis, umbilical vasculitis or acute funisitis. 3 Despite major advances in neonatal intensive care, bronchopulmonary dysplasia (BPD) remains a major clinical problem in preterm infants and results in increased health care costs, prolonged hospital stays and deleterious effects on subsequent growth and neurodevelopment. [4] [5] [6] The etiology of BPD is multifactorial. Proven risk factors for BPD include lower gestational age, lower birth weight, respiratory distress syndrome (RDS), sepsis, patent ductus arteriosus, oxygen supplementation and mechanical ventilation. 7, 8 Numerous studies have explored the relationship between chorioamnionitis and BPD with conflicting results. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] A recent meta-analysis suggested that chorioamnionitis is significantly associated with BPD; however, there was strong evidence of publication bias, suggesting potential overestimation of the measure of association between chorioamnionitis and BPD. 22 This meta-analysis did not analyze the association between histological chorioamnionitis (HC) with or without FIR and BPD. Several studies have reported that HC is associated with a reduced risk of RDS. 9, 16, 17, 23, 24 As chorioamnionitis decreases the risk of RDS, an important predictor of BPD, it is counterintuitive that chorioamnionitis should increase the risk of BPD. The inconsistency in the association between chorioamnionitis and BPD may be due to differences in study design, populations, varying definitions of chorioamnionitis and BPD, or due to lack of adjustment for potential confounding variables such as gestational age, and antenatal steroids. 21, 22 Very few studies have evaluated the effects of HC with and without fetal involvement on BPD. 20, 24 The objective of this study is to examine the association between HC with or without FIR and BPD in infants born at o29 weeks gestation, after adjusting for perinatal and neonatal risk factors.
METHODS

Study design and study population
This was a retrospective cohort study. The study cohort consisted of preterm infants of gestational age o29 weeks admitted to the regional Neonatal Intensive Care Unit (NICU) in Southern Alberta, Canada between 1 January 2000 and 31 December 2006. This NICU is the only tertiary care perinatal center in Southern Alberta, with B20 000 deliveries annually in its catchment area. Infants with major congenital or chromosomal anomalies and those without placental examination were excluded from 1 the study. The study was approved by the Conjoint Health Research Ethics Board of the Faculty of Medicine, University of Calgary, and a waiver of consent was permitted for the retrospective study.
The perinatal and neonatal outcome data were extracted from the perinatal follow-up database. This database contains maternal and neonatal information collected from patient charts by trained data abstractors in accordance with a local manual of standardized operational definitions for variables and outcomes. We abstracted the following variables for this study: maternal age, antenatal risk factors such as pregnancy-induced hypertension, prolonged rupture of membrane (PROM 424 h), clinical chorioamnionitis (defined as the presence of maternal fever and/or foul-smelling amniotic fluid), maternal antibiotic use, gestational age, birth weight, sex, antenatal steroids, mode of delivery, multiple or singleton pregnancy, Apgar scores, umbilical arterial pH, RDS, patent ductus arteriosus, culture-proven sepsis, necrotizing enterocolitis, BPD, mortality, duration of ventilation and hospital stay.
During the study period, placental histological examination was carried out by the anatomic pathologist using standard techniques. After delivery, fresh placentas sent to the pathology laboratory were examined, sampled and then placed in 10% formalin. Sections for microscopic examination were taken from each placenta as follows: (a) two from the fetal side of the placenta, (b) two from the maternal side of the placenta and (c) one membrane roll and (d) two sections from the umbilical cord, one from the proximal portion, another from the distal portion of the cord. In case of multiple gestations, in addition to routine sections, a section of the dividing membranes was also submitted. The sections were embedded in paraffin, sectioned, stained with hematoxylin and eosin, and examined microscopically. For this study, HC was defined by the presence of polymorphonuclear leukocyte infiltration in the placental membranes, chorionic plate or umbilical cord. HC with FIR was diagnosed if there was involvement of the chorionic vessels or umbilical cord. On the basis of histological findings, exposure status was classified as no HC, HC without FIR and HC with FIR.
Definitions
Gestational age in completed weeks was estimated from the best obstetric estimate by using ultrasonography and/or the date of the last menstrual period or both. Small for gestational age was defined as birth weight o10th percentile for gestational age. 25 RDS was defined as the presence of respiratory symptoms, typical chest X-ray findings and/or treatment with surfactant. Patent ductus arteriosus was defined as clinical and echocardiographic diagnosis plus pharmacological treatment, surgical ligation or both. Sepsis was defined as positive single organism cultures from blood or cerebrospinal fluid during the hospital stay. Necrotizing enterocolitis was defined according to modified Bell's criteria. 26 BPD was defined as supplemental oxygen dependency or any form of assisted ventilation at 36 weeks postmenstrual age. 27 
Statistical Analyses
We compared the maternal and neonatal outcomes among the three groups (that is no HC, HC without FIR and HC with FIR) using one-way analysis of variance or Kruskal-Wallis test for continuous variables, and w 2 -test or Fisher's exact test for categorical variables. Continuous variables were expressed as mean±s.d. if normally distributed, and median and interquartile range if not normally distributed.
The association between HC and BPD or the combined outcome for BPD or death before 36 weeks were examined using generalized estimating equations with a binomial distribution and a log link in order to account for correlations in multiple births. A log link was used in order to report risk ratios (RR), as odds ratios could have been misleading with the high prevalence of BPD in preterm infants. 28 Owing to the difficulties of fitting the model given the sample size, an exchangeable correlation matrix was assumed, and gestational age was converted into three categories, 23 to 24 weeks, 25 to 26 weeks, and 27 to 28 weeks. All associations between HC and the outcomes were checked sequentially adjusting for gestational age, mode of delivery, a multiple birth indicator, antenatal steroids, maternal hypertension, PROM and small for gestational age. Although associations were sometimes found between these variables and the outcomes, they were only retained in the model if they confounded the relationship between HC and the outcome. RR and 95% confidence intervals (CI) were computed for outcomes. A two-tailed P valueo0.05 was considered statistically significant. Statistical analyses were carried out using SAS 9.2. (SAS Institute, Cary, NC, USA).
RESULTS
During the study period, a total of 628 infants of gestational age o29 weeks were admitted to the NICU. Ninety-nine infants were excluded due to the lack of placental histology report (93), multiple congenital anomalies (4) or syndrome (2) . There was no significant difference in the demographic parameters between excluded and included infants in the study except for a higher birth weight in excluded infants. Figure 1 shows the flow diagram of the study population. Of the 529 infants, 259 (49%) showed no evidence of HC, 84 (16%) infants had HC without FIR and the remaining 186 (35%) had HC with FIR. The maternal and neonatal characteristics of the three groups are presented in Table 1 . Mothers with HC with or without FIR were more likely to have prolonged rupture of membranes (PROM424 h), clinical chorioamnionitis and treated with antibiotics. Both HCexposed groups were of lower gestational age, were more likely to be singleton, and had lower 5 min Apgar scores. Infants without HC were more likely to be born to mothers with pregnancyinduced hypertension, were more likely to be small for gestational age and more likely to be delivered by cesarean section. Table 2 shows the comparison of neonatal outcomes among the three groups. There were no differences in the rates of RDS, surfactant therapy or confirmed sepsis among the three groups. Of the 529 infants, 80 (15%) died before 36 weeks postmenstrual age. There was no difference in mortality rates among the three groups.
The outcome of BPD was available for 444 of 449 (99%) survivors. Five infants did not have data on BPD (two each in the HC with and without FIR groups and one in the no HC group). BPD was diagnosed in 327 (73%) of 444 infants. The mean (s.d.) gestational age was 26 ± 1.4 weeks for infants with BPD and 27.1±1.0 weeks for infants without BPD (Po0.001). In the bivariate analysis, HC with or without FIR was associated with decreased incidence of BPD and the combined outcome of BPD or death as compared with no HC group. Table 3 shows the final multivariable regression model for BPD and the combined outcome of BPD or death. The associations for BPD and the combined outcome of BPD or death before discharge are adjusted by gestational age categories, as adjustment by other potential confounding variables did not significantly alter the results. HC with FIR was associated with a significant reduction in the risk for BPD (adjusted RR, aRR: 0.88, 95% CI: 0.81 to 0.95) and the combined outcome of BPD or death (aRR: 0.91, 95% CI: 0.86 to 0.97). Similarly, there was a strong trend for HC without FIR to be protective for BPD (aRR: 0.93, 95% CI: 0.86 to 1.00) and the combined outcome of BPD or death (aRR: 0.97, 95% CI: 0.94 to 1.01). Chorioamnionitis and bronchopulmonary dysplasia N Plakkal et al
DISCUSSION
In this cohort of preterm infants, we found that HC with or without FIR was associated with significantly decreased risk of BPD. Chorioamnionitis with FIR was also protective for the combined outcome of BPD or death. Findings similar to ours have been reported previously. 20, 29 In a cohort study from Australia, Lahra et al 20 reported that HC with umbilical vasculitis was protective for BPD in infants born at o30 weeks gestation, and that HC without funisitis showed a trend towards protection for BPD. They hypothesized that chorioamnionitis protected against BPD by reducing the risk of RDS and associated mechanical ventilation. Similarly, Lyon et al 29 observed that infants exposed to HC were significantly less likely to develop BPD.
The association between chorioamnionitis and BPD has been controversial. A meta-analysis of studies published before 2009 suggested that chorioamnionitis was associated with increased odds of developing BPD (adjusted odds ratio 1.58, 95% CI 1.11 to 2.24). 22 This meta-analysis-pooled data from studies that used varied definitions of chorioamnionitis (histological, clinical or microbiological). The authors reported a strong evidence of publication bias, suggesting potential exaggeration of the magnitude of the association between chorioamnionitis and BPD. When controlling for publication bias, the results were more conservative and adjusted results were no longer significant. Lahra et al 23 had earlier shown that HC with and without fetal involvement were both associated with decreased RDS risk in infants. We did not find any statistically significant differences in the rates of RDS among the three groups. However, we noticed a trend towards decreased use of surfactant in the HC groups, despite their gestational ages being lower. During the study period, it was standard practice to intubate and administer prophylactic surfactant at birth to all infants o27 weeks in our institution. The study by Lahra et al included older (mean Chorioamnionitis and bronchopulmonary dysplasia N Plakkal et al gestational age 27.4 ± 1.5 weeks) infants and used different diagnostic criteria for RDS than the present study. The differences in the study populations and the definitions used for RDS might explain why we did not find a difference in the incidence of RDS.
In a recent prospective cohort study of infants (p32 weeks), HC without fetal involvement was associated with decreased risk of severe RDS. 24 However, the effect of HC with fetal involvement on the incidence of severe RDS was dependent on the gestational age. The authors noted a trend for increased risk of severe RDS in older infants (30 weeks) but a decreased risk in younger infants (26 to 28 weeks). The study highlighted the role of gestational age as a crucial determinant of pulmonary outcome in the complex relationship between prenatal inflammation, antenatal steroids and RDS. Although RDS itself is an important outcome and an important predictor of BPD, our study focused on younger infants who are at the highest risk of developing BPD. It is possible that the effect of chorioamnionitis on BPD is also gestational agedependent. Watterberg et al reported a decreased risk of RDS but an increased risk of BPD in infants exposed to HC. 9 However, the Watterberg study predated the use of routine prenatal steroids, and none of the babies in the study received surfactant. The infants exposed to chorioamnionitis were of lower gestational age, but the data were not adjusted for gestational age.
In the United States, the incidence of BPD was 68% among infants o29 weeks gestation using the newer severity-based definition and 42% using the traditional definition. 30 BPD developed in 90% of infants o29 weeks using the newer severity-based definition and in 47% using the traditional definition in a Norwegian national cohort. 31 The overall incidence of BPD (73%) in our cohort of infants was high when using the traditional definition of supplemental oxygen use at 36 weeks. Calgary is located at an elevation of 1112 m above sea level. 32 At higher altitudes, there is an increased risk of hypoxia, which increases the need for oxygen in preterm infants with lung disease. 33 Increased administration of oxygen in turn may further exacerbate oxidative lung injury. 34, 35 Britton recently reported a high BPD rate among very low birth-weight infants using the current definition at high altitude and discussed the limitations of using oxygen dependency at 36 weeks alone for the diagnosis of BPD. 36 Future definition of BPD should take altitude into account and make corresponding corrections to oxygen requirement. Although altitude may be one of the factors contributing to the high incidence of BPD in our cohort, it is very likely that other factors are involved, including difference in the population characteristics and respiratory management of these infants.
Redline et al. 12 reported that chorioamnionitis was associated with a decreased risk of BPD among non-white infants. The impact of genetics on BPD is increasingly apparent 37 and has been recently reviewed. 38, 39 The strengths of this study include a large sample size from a regionalised health care system, and a study population more representative of the current NICU population when compared with older studies. The study spanned a period of 7 years, and it is possible that changes in clinical practice occurred during this time. However, there were no major changes in mechanical ventilation protocols, oxygen saturation targets or indications for surfactant therapy for RDS in the unit. Antenatal steroid use remained high throughout the study period. The limitations of the study include its retrospective nature, inability to classify the severity of BPD and inability to use the physiological definition of BPD, which only became available in 2003. Placental histology was not available for outborn infants; exclusion of these infants is a potential source of bias. With the use of prophylactic surfactant, the diagnosis of RDS may be overestimated. Our findings of reduced risk of BPD with HC have to be interpreted against the background of a relatively high altitude. Finally, HC and the FIR are not binary physiological responses but represent two ends of a spectrum. Besides, BPD is not a binary outcome per se, and the severity of BPD may determine long-term pulmonary outcomes.
CONCLUSIONS
In conclusion, HC with FIR is associated with a reduced risk of BPD in preterm infants. Future research should be directed at examining the correlation between the severity of chorioamnionitis and the severity of BPD. Chorioamnionitis and bronchopulmonary dysplasia N Plakkal et al
